Related Experiment Video
Updated: Jun 16, 2025

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Common protein networks for various drug regimens of major depression are associated with complement and immunity
Seungyeon Lee1, Sora Mun2, Jiyeong Lee3
1Department of Senior Healthcare, Graduate School, Eulji University, Uijeongbu, Republic of Korea.
Background:
Major depressive disorder (MDD) can present a variety of clinical presentations and has high inter-individual heterogeneity. Multiple studies have suggested various subtype models related to symptoms, etiology, sex, and treatment response. Employing different regimens is common when treating MDD, and identifying effective therapeutics requires time. Frequent treatment attempts and failures can lead to a diagnosis of treatment resistance, and the heterogeneity of treatment responses among individuals makes it difficult to understand and interpret the biological mechanisms underlying MDD.
Aim:
This study explored the differentially expressed proteins and commonly altered protein networks across drug treatments by comparing the serum proteomes of patients with MDD treated with drug regimens (T-MDD, n = 20) and untreated patients (NT-MDD, n = 20).
Methods:
Differentially expressed proteins were profiled in non-drug-treated and drug-treated patients with depression using liquid chromatography-mass spectrometry. The common protein networks affected by different medications were studied.
Results:
Of the proteins profiled, 12 were significantly differentially expressed between the T-MDD and NT-MDD groups. Commonly altered proteins and networks of various drug treatments for depression were related to the complement system and immunity.
Conclusions:
Our results provide information on common biological changes across different pharmacological treatments employed for depression and provide an alternative perspective for improving our understanding of the biological mechanisms of drug response in MDD with great heterogeneity in the background of the disease.
Insights
This study compared serum proteins in treated and untreated major depressive disorder (MDD) patients. Key differences involved immune and complement system proteins, offering insights into MDD treatment mechanisms.
Area of Science:
- Biochemistry
- Neuroscience
- Immunology
Background:
- Major depressive disorder (MDD) exhibits significant heterogeneity in clinical presentation and treatment response.
- Identifying effective MDD therapeutics is challenging due to inter-individual variability and treatment resistance.
- Understanding the biological mechanisms underlying MDD heterogeneity and treatment response is crucial.
Purpose of the Study:
- To explore differentially expressed proteins in the serum of drug-treated (T-MDD) versus untreated (NT-MDD) patients.
- To identify commonly altered protein networks affected by various antidepressant drug regimens.
- To gain insights into the biological underpinnings of MDD treatment response.
Main Methods:
- Serum proteomes of 20 T-MDD patients and 20 NT-MDD patients were analyzed.
- Liquid chromatography-mass spectrometry (LC-MS) was employed for protein profiling.
- Differential protein expression and network analysis were conducted.
Main Results:
- Twelve proteins were significantly differentially expressed between the T-MDD and NT-MDD groups.
- Commonly altered protein networks across different depression treatments were identified.
- These networks were primarily associated with the complement system and immune responses.
Conclusions:
- The study identified common biological changes associated with pharmacological MDD treatments.
- Findings suggest a role for the immune system and complement pathways in MDD drug response.
- This research offers a novel perspective on MDD's biological mechanisms, particularly concerning treatment heterogeneity.
More Related Videos
Related Concept Videos
Complement System
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
G-protein Coupled Receptors
Antidepressant Drugs: MAOIs and Other Agents
Protein-protein Interfaces

